カンザス州におけるクローン病の臨床試験
カンザス州内の拠点で、クローン病に関する11件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Kansas Medical Center ( Site 5091), Kansas City
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Cotton-O'Neil Clinical Research Center, Topeka
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Kansas Gastroenterology, LLC, Wichita
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center, Kansas City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06233461Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- 他7件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center-Site Number: 8400110, Kansas City
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Kansas Medical Center, Kansas City
- Cotton ONeil Clinical Research Center, Topeka
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT06045754A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400006, Kansas City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/03/27更新 · NCT06958536ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。